Nethanel Asher
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
- Cutaneous Melanoma Detection and Management
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 17
- CAR-T cell therapy research 11
- Cutaneous Melanoma Detection and Management 5
- Colorectal Cancer Treatments and Studies 4
-
- Melanoma and MAPK Pathways 9
- Co-authors
- Gal Markel (14 shared papers)Guy Ben‐Betzalel (18 shared papers)Ronnie Shapira‐Frommer (19 shared papers)Jacob Schachter (12 shared papers)Yael Steinberg‐Silman (5 shared papers)Tomer Meirson (5 shared papers)Erez N. Baruch (4 shared papers)David Bomze (2 shared papers)
- Journals
- Cancers (4 papers)Journal of Clinical Oncology (3 papers)European Journal of Cancer (2 papers)Cancer Immunology Research (2 papers)Molecular Carcinogenesis (1 paper)
- Partner nations
- IsraelNetherlandsSwitzerland
In The Last Decade
Nethanel Asher
28 papers receiving 448 citations
Peers
Comparison fields: 5 of 65
- Oncology 334
- Immunology 115
- Pulmonary and Respiratory Medicine 70
- Molecular Biology 117
- Genetics 18
Countries citing papers authored by Nethanel Asher
This map shows the geographic impact of Nethanel Asher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nethanel Asher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nethanel Asher more than expected).
Fields of papers citing papers by Nethanel Asher
This network shows the impact of papers produced by Nethanel Asher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nethanel Asher. The network helps show where Nethanel Asher may publish in the future.
Co-authors
The 25 scholars most cited alongside Nethanel Asher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 46 | |
| 2 | 2021 | 46 | |
| 3 | 2020 | 44 | |
| 4 | 2019 | 43 | |
| 5 | 2019 | 35 | |
| 6 | 2018 | 27 | |
| 7 | 2020 | 24 | |
| 8 | 2021 | 24 | |
| 9 | 2020 | 22 | |
| 10 | 2020 | 22 | |
| 11 | 2023 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 11 | |
| 14 | 2023 | 11 | |
| 15 | 2021 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2021 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2019 | 7 |
About Nethanel Asher
Nethanel Asher is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 31 papers that have together received 454 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), CAR-T cell therapy research (11 papers), Melanoma and MAPK Pathways (9 papers), Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Brain Metastases and Treatment (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Oncology (334 citations), Immunology (115 citations), Pulmonary and Respiratory Medicine (70 citations), Molecular Biology (117 citations) and Genetics (18 citations). Nethanel Asher has collaborated with scholars based in Israel, Netherlands and Switzerland. Frequent co-authors include Gal Markel, Guy Ben‐Betzalel, Ronnie Shapira‐Frommer, Jacob Schachter, Yael Steinberg‐Silman, Tomer Meirson, Erez N. Baruch, David Bomze, Ben Boursi and Orit Itzhaki. Their work appears in journals such as Cancers, Journal of Clinical Oncology, European Journal of Cancer, Cancer Immunology Research and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.